A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

Summary

This study aims to provide a basis for further clinical development of YKST02. YKST02 is a study medicine that targets multiple myeloma and activates the human body to fight against this disease.

Timeline

Start

2024-06-14

Primary completion

2026-12-31

Completion

2027-06-30

Drugs

Indications